Wilms’ tumor 1-associating protein promotes renal cell carcinoma proliferation by regulating CDK2 mRNA stability

Cited by papers we hold 7

• The RNA m6A writer WTAP in diseases: structure, roles, and mechanisms · 2022
  No notice
• A review on the role of cyclin dependent kinases in cancers · 2022
  No notice
• WTAP-mediated N6-methyladenosine modification of NLRP3 mRNA in kidney injury of diabetic nephropathy · 2022
  No notice
• Role of main RNA modifications in cancer: N6-methyladenosine, 5-methylcytosine, and pseudouridine · 2022
  No notice
• Mechanism of RNA modification N6-methyladenosine in human cancer · 2020
  No notice
• WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1 · 2019
  No notice
• The interplay between m6A RNA methylation and noncoding RNA in cancer · 2019
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.